5月28日，Intellia Therapeutics盘中上涨8.01%，报13.62美元/股，成交额7197.21万美元。
Intellia Therapeutics所在的生物科技行业中，个股中，再生元制药公司跌0.43%，艾伯维公司涨1.12%，安进涨0.47%，福泰制药涨0.71%，吉利德科学涨0.04%。
Intellia Therapeutics是一家领先的基因编辑公司，专注于利用CRISPR/Cas9系统生物工具开发潜在治愈性疗法，致力于通过单一疗程永久编辑疾病相关基因，发展新一代治疗产品。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.